The objective of the clinical study of the medicinal product for medical use: to compare efficacy and safety of the generic drug BCD-063 and Copaxone®-Teva in patients with relapsing-remitting multiple sclerosis.
Period of the clinical study of the medicinal product for medical use: from June 10, 2013 to March 23, 2016.
Number of patients, involved into the study of the medicinal product for medical use: 158 patients.
The objective of the clinical study of the medicinal product for medical use: to compare efficacy and safety of the generic drug BCD-063 and Copaxone®-Teva in patients with relapsing-remitting multiple sclerosis.
Period of the clinical study of the medicinal product for medical use: from June 10, 2013 to March 23, 2016.
Number of patients, involved into the study of the medicinal product for medical use: 158 patients.
Diseño del estudio»Ensayo controlado aleatorizado (ECA)
